Evan Kreiner has extensive experience defending clients across all phases of antitrust and general commercial litigations and government investigations, securing successful outcomes for companies facing significant exposure in high-stakes class actions and cutting-edge, bet-the-company trials.
Kreiner represents clients in a broad spectrum of industries, including technology, health care and financial services, and his experience covers a diverse array of matters, from state and federal antitrust and unfair competition claims to contractual disputes.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2026 Lawdragon 500 Leading Global Antitrust & Competition Lawyers | 2026 | Antitrust Litigation |
| The 2025 Lawdragon 500 X – The Next Generation | 2025 | Antitrust & Competition |
Clients regularly turn to Kreiner for his unique combination of deep antitrust acumen and trial experience, including with regard to government-initiated merger challenges and jury trials involving complex economic issues. He provides comprehensive guidance to clients throughout every stage of the litigation process, from attempts to resolve litigation before a complaint is filed through trials and appeals.
Kreiner’s representative matters include:
- Greystar Real Estate Partners, LLC in investigations and litigations brought by the DOJ, state attorneys general and a putative nationwide class of renters alleging that multifamily property managers violated antitrust laws and inflated rents through the use of RealPage revenue management software
- American Surety Company and its CEO in securing a favorable settlement in a putative class action that asserted state and federal antitrust claims
- JPMorgan Chase in multiple antitrust class actions regarding credit and debit card interchange fees and network rules (argued successful motion to dismiss on behalf of multiple bank defendants in B&R Supermarkets v. Visa, et al.)
- SmartSky Networks in litigation against Gogo alleging that Gogo violated state and federal antitrust laws by engaging in unlawful monopolistic conduct
- American Express Global Business Travel in securing the dismissal of the DOJ’s lawsuit challenging Amex GBT’s $540 million acquisition of CWT
- Watson Pharmaceuticals, Inc. and current and former affiliates in class action alleging anticompetitive reverse payment settlement regarding branded drug Lidoderm
- Postmates in a class action alleging price fixing and anticompetitive conduct regarding online meal ordering platforms